Daclatasvir-impurities | Pharmaffiliates

daclatasvir

Daclatasvir is used only in combination therapy for the treatment of hepatitis C genotype 1, 3, or 4 infections.. Reference standards of Daclatasvir API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below

stdClass Object
(
    [pname] => (2R)-2-(Methoxycarbonylamino)-3-methylbutanoic Acid
    [catalogue_number] => PA 04 94510
    [category_ids] => ,79,92,
    [chemical_name] => 
    [weight] => 175.18
    [form] => C7H13NO4
    [cas] => 171567-86-5
    [pslug] => 171567-86-5-2r-2-methoxycarbonylamino-3-methylbutanoic-acid-pa0494510
    [latest_product] => 0
    [linkproducts] => 0
    [offers_id] => 
    [offers_name] => 
    [offers_status] => 
    [offers_start_date] => 
    [offers_end_date] => 
    [pageview] => 
    [offers_slug] => 
    [offers_product_id] => 
    [offers_product_code] => 
    [offers_master_id] => 
    [offer_percentage] => 
    [offers_product_main_cat] => 
)
PA 04 94510

(2R)-2-(Methoxycarbonylamino)-3-methylbutanoic Acid


  • Catalogue No.:PA 04 94510

  • CAS :

    171567-86-5

  • Molecular Formula : C7H13NO4

  • Molecular Weight : 175.18